Reuters logo
BRIEF-Tracon Pharmaceuticals announces first patient dosed in phase 3 TAPPAS trial
February 16, 2017 / 1:24 PM / 9 months ago

BRIEF-Tracon Pharmaceuticals announces first patient dosed in phase 3 TAPPAS trial

Feb 16 (Reuters) - Tracon Pharmaceuticals Inc :

* Tracon Pharmaceuticals announces first patient dosed in phase 3 tappas trial of TRC105 in angiosarcoma Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below